MicroRNA-128a, BMI1 polycomb ring finger oncogene, and reactive oxygen species inhibit the growth of U-87 MG glioblastoma cells following exposure to X-ray radiation

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 6247-6254

  Ye, Lan ^a   Yu, Guanying ^b   Wang, Cuihong ^a   Du, Bin ^b   Sun, Dianshui ^a   Liu, Junli ^a   Qi, Tonggang ^a   Yu, Xiaoming ^a   Wei, Wei ^a   Cheng, Jian ^a   Jiang, Yuhua ^a  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

BMI1 polycomb ring finger oncogene; Glioma; Microrna 128a; Radioresistance; Reactive oxygen species

Indexed keywords

BMI1 PROTEIN; MICRORNA; MICRORNA 128A; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; BMI1 PROTEIN, HUMAN; MESSENGER RNA; MIRN128 MICRORNA, HUMAN;

ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE ARREST; CELL GROWTH; CONTROLLED STUDY; G2 PHASE CELL CYCLE CHECKPOINT; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; GLIOMA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY; REVERSE TRANSCRIPTION; SIGNAL TRANSDUCTION; X RAY; APOPTOSIS; CELL PROLIFERATION; DOWN REGULATION; GENETICS; METABOLISM; PATHOLOGY; RADIATION RESPONSE; RADIATION TOLERANCE; TUMOR CELL LINE;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOWN-REGULATION; GLIOBLASTOMA; HUMANS; MICRORNAS; POLYCOMB REPRESSIVE COMPLEX 1; RADIATION TOLERANCE; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIGNAL TRANSDUCTION; X-RAYS;

EID: 84940485512     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4175     Document Type: Article

References (34)

1. Haris K, Ismail S, Idris Z, Abdullah JM and Yusoff AA: Expression profile of genes modulated by Aloe emodin in human U87 glioblastoma cells. Asian Pac J Cancer Prev 15: 4499-4505, 2014.
2. Lee JH, Jung TY, Jung S, Kim IY, Jang WY, Moon KS and Jeong EH: Performance status during and after radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme. J Clin Neurosci 20: 503-508, 2013.
3. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, et al; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466, 2009.
4. Wick W, Weller M, van den Bent M, Sanson M, Weiler M, von Deimling A, Plass C, Hegi M, Platten M and Reifenberger G: MGMT testing-the challenges for biomarker-based glioma treatment. Nat Rev Neurol 10: 372-385, 2014.
5. Errafy R, Aguado C, Ghislat G, Esteve JM, Gil A, Loutf M and Knecht E: PTEN increases autophagy and inhibits the ubiquitin-proteasome pathway in glioma cells independently of its lipid phosphatase activity. PLoS One 8: e83318, 2013.
6. Lim YC, Roberts TL, Day BW, Harding A, Kozlov S, Kijas AW, Ensbey KS, Walker DG and Lavin MF: A role for homologous recombination and abnormal cell-cycle progression in radio-resistance of glioma-initiating cells. Mol Cancer Ther 11: 1863-1872, 2012.
7. Ketting RF: microRNA biogenesis and function: An overview. Adv Exp Med Biol 700: 1-14, 2011.
8. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
9. Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S, Hammond SM, Bartel DP and Schier AF: MicroRNAs regulate brain morphogenesis in zebrafish. Science 308: 833-838, 2005.
10. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
11. Png KJ, Halberg N, Yoshida M and Tavazoie SF: A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481: 190-194, 2012.
12. Macfarlane LA and Murphy PR: MicroRNA: Biogenesis, function and role in cancer. Curr Genomics 11: 537-561, 2010.
13. Kumar MS, Lu J, Mercer KL, Golub TR and Jacks T: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677, 2007.
14. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R and Shah K: MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67: 8994-9000, 2007.
15. Cui QK, Liu WD, Zhu JX, Wang YH and Wang ZG: MicroRNA-184 promotes proliferation ability of glioma cells by regulating FOXO3. Asian Pac J Trop Med 7: 776-779, 2014.
16. Hu X, Chen D, Cui Y, Li Z and Huang J: Targeting microRNA-23a to inhibit glioma cell invasion via HOXD10. Sci Rep 3: 3423, 2013.
17. Ye L, Wang C, Yu G, Jiang Y, Sun D, Zhang Z, Yu X, Li X, Wei W, Liu P, et al: Bmi-1 induces radioresistance by suppressing senescence in human U87 glioma cells. Oncol Lett 8: 2601-2606, 2014.
18. Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG: Extensive modulation of a set of microRNAs in primary glio-blastoma. Biochem Biophys Res Commun 334: 1351-1358, 2005.
19. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125-9130, 2008.
20. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
21. Murayama S, Kawai R, Hirabuki N, Miura T, Mitomo M, Kozuka T and Usio Y: Intra-arterial ACNU chemotherapy of malignant glioma. Nihon Igaku Hoshasen Gakkai Zasshi 48: 144-153, 1988 (In Japanese).
22. Taylor LP: Diagnosis, treatment, and prognosis of glioma: Five new things. Neurology (18 Suppl 1) 75: S28-S32, 2010.
23. Clarke J, Butowski N and Chang S: Recent advances in therapy for glioblastoma. Arch Neurol 67: 279-283, 2010.
24. Delaney G, Jacob S, Featherstone C and Barton M: The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104: 1129-1137, 2005.
25. Schmitt CA: Cellular senescence and cancer treatment. Biochim Biophys Acta 1775: 5-20, 2007.
26. Roninson IB: Tumor cell senescence in cancer treatment. Cancer Res 63: 2705-2715, 2003.
27. Molofsky AV, He S, Bydon M, Morrison SJ and Pardal R: Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 19: 1432-1437, 2005.
28. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843, 2005.
29. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: Genetics and biology of a grave matter. Genes Dev 15: 1311-1333, 2001.
30. Hara E, Smith R, Parry D, Tahara H, Stone S and Peters G: Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859-867, 1996.
31. Zhang Y, Xiong Y and Yarbrough WG: ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725-734, 1998.
32. Venkataraman S, Alimova I, Fan R, Harris P, Foreman N and Vibhakar R: MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. PLoS One 5: e10748, 2010.
33. Finkel T: Signal transduction by reactive oxygen species in non-phagocytic cells. J Leukoc Biol 65: 337-340, 1999.
34. Bauer G: Low dose radiation and intercellular induction of apoptosis: Potential implications for the control of oncogenesis. Int J Radiat Biol 83: 873-888, 2007.